Finance

Lists
DSGN:NASDAQ
Design Therapeutics Inc
US$ ११.६५
+१.३९%
(+०.१६) 1D
US$ ११.६५
०.००% (०.००)
After hours
Closed: अक्टोबर ९, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DSGN...
Open
US$ ११.४७
High
US$ ११.९२
Low
US$ ११.४०
Mkt. cap
७२.९१ करोड
Avg. vol.
७.०८ लाख
Volume
३.५७ लाख
52-wk high
US$ १७.२५
52-wk low
US$ ५.२८
EPS
-US$ १.१८
Beta
१.६८
Shares outstanding
६.२६ करोड
No. of employees
५५
Open
US$ ११.४७
High
US$ ११.९२
Low
US$ ११.४०
Mkt. cap
७२.९१ करोड
Avg. vol.
७.०८ लाख
Volume
३.५७ लाख
52-wk high
US$ १७.२५
52-wk low
US$ ५.२८
EPS
-US$ १.१८
Beta
१.६८
Shares outstanding
६.२६ करोड
No. of employees
५५
News stories
From web sources and news partners
About Design Therapeutics Inc
CEO-
Employees५५
Founded२०१७
Headquartersकार्ल्सबेड, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to DSGN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for DSGN in the last 3 months.
Highest
Current US$ ११.६५
US$ ४०.५४ (+२४७.९८%)
Average
US$ २७.१४ (+१३२.९६%)
Lowest
US$ २०.०० (+७१.६७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tianqi Hang
Wells Fargo
Buy
Initiated
US$ २६.००
+१२३.२%
10/02/2026
Unknown Analyst
Wells Fargo
Buy
Initiated
US$ २६.००
+१२३.२%
10/02/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Maintained
US$ ४०.५४
+२४८%
08/05/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
US$ २२.००
+८८.८%
08/04/2026
Leonid Timashev
RBC Capital
Buy
Maintained
US$ २०.००
+७१.७%
08/03/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
US$ २१.००
+८०.३%
06/15/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ २०.००
+७१.७%
05/27/2026
Faisal Khurshid
Jefferies
Buy
Initiated
US$ १५.००
+२८.८%
03/15/2026
Luca Issi
RBC Capital
Buy
Reiterated
US$ १४.००
+२०.२%
03/09/2026
Last report
२०२६ अगस्ट ३
Fiscal period
Q2 2026
-US$ ०.३२ / -US$ ०.३४
+७.०६%beat
Revenue / Est. (USD)
- / ०.००
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
१.४६ करोड
१.३४ करोड
१.४४ करोड
१.६४ करोड
Cost of revenue
१.४६ करोड
१.३४ करोड
१.४४ करोड
१.६४ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४७.२२ लाख
४७.४४ लाख
५३.२७ लाख
५७.८९ लाख
Operating expense
४७.२२ लाख
४७.४४ लाख
५३.२७ लाख
५७.८९ लाख
Total operating expenses
१.९३ करोड
१.८२ करोड
१.९७ करोड
२.२२ करोड
Operating income
-१.९३ करोड
-१.८२ करोड
-१.९७ करोड
-२.२२ करोड
Other non operating income
-
-
-
-
EBT including unusual items
-१.७० करोड
-१.६० करोड
-१.७६ करोड
-२.०२ करोड
EBT excluding unusual items
-१.७० करोड
-१.६० करोड
-१.७६ करोड
-२.०२ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.७० करोड
-१.६० करोड
-१.७६ करोड
-२.०२ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.३०
-०.२७
-०.२९
-०.३२
Interest and investment income
२३.१४ लाख
२१.७२ लाख
२०.७० लाख
२०.१२ लाख
Interest expense
-
-
-
-
Net interest expenses
२३.१४ लाख
२१.७२ लाख
२०.७० लाख
२०.१२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.९२ करोड
-१.८० करोड
-१.९५ करोड
-२.२० करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू